TLR2 and neoplasm: Mmp2 overexpression in tumor cells is therefore likely to impact other pathways beyond Tlr2/4 signaling that contribute to tumor growth — e.g., degradation of ECM proteins to modify the TME architecture or degradation of IFNAR1 in immune cells (APCs or other cell types) as we previously showed (8).